Frequently Asked Questions
The market is segmented based on Global Anti-Infective Drugs Market, By Product Type (Antibiotics, Antivirals, Antifungals, Others), Indication (HIV Infections, Pneumonia, Hepatitis, Herpes Simplex Virus, Influenza, Others), Route of Administration (Oral, Topical, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Anti Infective Drugs Market size was valued at USD 135.00 USD Billion in 2022.
The Global Anti Infective Drugs Market is projected to grow at a CAGR of 4% during the forecast period of 2023 to 2030.
The major players operating in the market include Takeda Pharmaceutical Company Limited, Johnsons & Johnsons Services , Boehringer Ingelheim International GmbH, Abbvie , Sun Pharmaceutical Industries Ltd, Sanofi, GSK Plc, Novartis AG, Pfizer , Amneal Pharmaceuticals LLC, Alvogen, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Alembic Pharmaceuticals Limited, Zydus Group.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
